• DVM360_Conference_Charlotte,NC_banner
  • ACVCACVC
  • DVM 360
  • Fetch DVM 360Fetch DVM 360
DVM 360
dvm360 | Veterinary News, Veterinarian Insights, Medicine, Pet Care
dvm360 | Veterinary News, Veterinarian Insights, Medicine, Pet Care
By Role
AssociatesOwnersPractice ManagerStudentsTechnicians
Subscriptions
dvm360 Newsletterdvm360 Magazine
News
All News
Association
Breaking News
Conference Coverage
Education
Equine
FDA
Law & Ethics
Market Trends
Medical
Politics
Products
Recalls
Regulatory
Digital Media
dvm360 LIVE!™
Expert Interviews
The Vet Blast Podcast
Medical World News
Pet Connections
The Dilemma Live
Vet Perspectives™
Weekly Newscast
dvm360 Insights™
Publications
All Publications
dvm360
Firstline
Supplements
Vetted
Clinical
All Clinical
Anesthesia
Animal Welfare
Behavior
Cardiology
CBD in Pets
Dentistry
Dermatology
Diabetes
Emergency & Critical Care
Endocrinology
Equine Medicine
Exotic Animal Medicine
Feline Medicine
Gastroenterology
Imaging
Infectious Diseases
Integrative Medicine
Nutrition
Oncology
Ophthalmology
Orthopedics
Pain Management
Parasitology
Pharmacy
Surgery
Toxicology
Urology & Nephrology
Virtual Care
Business
All Business
Business & Personal Finance
Hospital Design
Personnel Management
Practice Finances
Practice Operations
Wellbeing & Lifestyle
Continuing Education
Conferences
Conference Listing
Conference Proceedings
Resources
CBD in Pets
CE Requirements by State
Contests
Veterinary Heroes
Partners
Spotlight Series
Team Meeting in a Box
Toolkit
Top Recommended Veterinary Products
Vet to Vet
  • Contact Us
  • Fetch DVM360 Conference
  • Terms and Conditions
  • Privacy
  • Do Not Sell My Information
  • About Us

© 2023 MJH Life Sciences and dvm360 | Veterinary News, Veterinarian Insights, Medicine, Pet Care. All rights reserved.

Advertisement
By Role
  • Associates
  • Owners
  • Practice Manager
  • Students
  • Technicians
Subscriptions
  • dvm360 Newsletter
  • dvm360 Magazine
  • Contact Us
  • Fetch DVM360 Conference
  • Terms and Conditions
  • Privacy
  • Do Not Sell My Information
  • About Us
  • MJHLS Brand Logo

© 2023 MJH Life Sciences™ and dvm360 | Veterinary News, Veterinarian Insights, Medicine, Pet Care. All rights reserved.

FDA releases long-awaited antibiotic guidelines

October 1, 2002

Washington-At presstime, the Food and Drug Administration (FDA) issued guidelines for animal drug evaluations to combat antibiotic resistance in people, Reuters reports.

Washington-At presstime, the Food and Drug Administration (FDA) issued guidelines for animal drug evaluations to combat antibiotic resistance in people, Reuters reports.

The FDA's draft guidance document lays out an approach for investigatingthe potential for causing drug resistance as part of the pre-approval evaluationof these drugs.

According to the FDA, national and international health organizationshave seen evidence that use of antimicrobial drugs in food-producing animalscould lead to the emergence of drug-resistant bacteria that can harm humans.

For instance, FDA says, Salmonella and Campylobacter can exist in thedigestive tract of food-producing animals without causing illness, but peoplecan suffer severe illness after consuming these bacteria in meat, milk oreggs.

"FDA's main concern is that use of antimicrobial drugs in food-producinganimals may lead to the emergence of bacterial pathogens that are resistantto drugs used to treat human illness, potentially making human illnessesmore difficult to treat," the agency says.

Advertisement

In January 1999, the FDA also issued a proposed framework for managingthe potential risk. According to the FDA, this risk assessment process willproduce an estimate of the potential risk posed to human health by the proposednew antimicrobial animal drug.

The agency states, "FDA believes that the potential human healthconsequences of exposure to the defined hazardous agent may be estimatedqualitatively by considering the human medical importance of the antimicrobialdrug in question."

FDA guidance documents are not legally binding, but they reflect theagency's preferred approach for dealing with specific issues.

Specific comments on the proposed methodology will be accepted for 75days following publication of the draft guidance document in the Sept. 13issue of the Federal Register, the agency says.

Related Content:

Regulatory
USDA aims to strengthen handling regulations for exotic animals in exhibition
USDA aims to strengthen handling regulations for exotic animals in exhibition
What you need to know about GFI #256 and the changing landscape of compounding medicine
What you need to know about GFI #256 and the changing landscape of compounding medicine
3 common misconceptions in controlled substance regulations
3 common misconceptions in controlled substance regulations

Advertisement

Latest News

Thriving when life is hard

Hospital design expert shares his favorite design element

Updated EquiTrace app integrates wth HISA Portal

San Francisco SPCA receives $100k grant from San Francisco Foundation

View More Latest News
Advertisement